Skip to product information
L-Lysine 2 g
L-Lysine 2 g

L-Lysine 2 g

Incl. VAT

Prescription

Dosage form: 20 ml infusion concentrate

Composition: L-lysine HCl, citric acid-phosphate buffer, water for injection

Prescription status: prescription only

Storage: store at room temperature

Shelf life: 1 year after manufacture

After completing your order, you will receive a link through which you can securely upload your prescription.
Anmeldung erforderlich
Jetzt einloggen Jetzt registrieren
PRODUCT INFORMATION

Composition: 

  • L-Lysine HCl 2000 mg 
  • Citric acid phosphate buffer 
  • Water for injection q.s. to 20 ml 

Administration: i.v., always prepare the infusion solution freshly as a single infusion, dilute in 100 ml of 0.9% NaCl 

Infusion set: Intrafix © Air P 

Infusion duration: 30 minutes 

Therapy interval: 2-3 times per week, based on the patient's health status 

Duration of treatment: 8 weeks, based on the patient's health status 

Storage: 15–25°C 

Shelf life: 1 year after manufacture

Side effects: none known 
THERAPY RECOMMENDATION

Positive Effects:

  • L-lysine is an essential amino acid. L-lysine is involved in calcium and collagen metabolism and is an important component of collagen and elastin.
  • L-lysine prevents calcium deposition in blood vessels.
  • L-lysine improves calcium incorporation into teeth and bones.
  • L-lysine promotes wound healing.
  • L-lysine has an antiviral effect because it acts antagonistically to L-arginine. In combination with vitamin C, the antiviral effect is enhanced.
  • L-lysine modulates anxiety and stress, and has an antidepressant effect.
  • L-lysine stimulates insulin receptor tyrosine kinase.
  • L-lysine positively supports LDL lipid metabolism.

Tip:For infections, combine with 15 g of vitamin C. For herpes infections, administer 4 g of L-lysine in combination with 15 g of vitamin C. First administer vitamin C, then the amino acid.

Therapeutic recommendations:There are indications that the properties of the substances contained in the product may have a positive effect on health disorders of the mentioned indications:

  • Increased skin elasticity and tightening, e.g., for connective tissue weakness.
  • For acute and chronic infections, common colds, herpes infections such as EBV, shingles, herpes simplex, CMV: therapeutic and for prevention of recurrent infections.
  • For diabetes mellitus type 2 and insulin resistance.
  • For hypercholesterolemia, cholesterol-lowering.
  • For arteriosclerosis.
  • For stress, reduction of cortisol.
  • For bone fractures.
  • For injuries, burns, etc.

Contraindications:Do not use in children under 6 years of age. For impaired kidney, liver, or heart function, and for albumin deficiency, an adjustment of the individual dose is recommended. Patients taking beta-blockers have an increased risk of a decompensated cardiovascular reaction, as beta-blockers inhibit the effect of adrenaline (emergency medical treatment). Patients with a tendency to allergic reactions and/or with diseases based on histamine release (e.g., asthma) should be asked about known allergens in accordance with the principles of therapeutic due diligence.

Note for physicians and therapists:For individual prescriptions, the physician/therapist fundamentally determines the indication. The suggestion is merely a recommendation for a therapy option, with the dosage and frequency of application being solely at the discretion of the physician/therapist. The treating therapist is responsible for the treatment and must individually check and assess the respective application for each patient before starting treatment.
Shipping Information

NATIONAL:

  • Standard shipping: €9.95 incl. VAT
  • Free shipping on orders over €200.00 (does not apply to refrigerated goods and express shipments)
  • Refrigerated and express shipping: €25.95 incl. VAT

Note: If individual products are unavailable, partial deliveries may occur, incurring no additional shipping costs.
Any requested partial deliveries will be charged.

WITHIN THE EU:
For shipments to countries in EU Zone 1, we charge logistics costs of €75.00 (incl. VAT).

For shipments to countries in EU Zone 2, we charge logistics costs of €105.00 (incl. VAT).

THIRD COUNTRIES:
The customer is asked to inquire about the logistics costs incurred for the respective country.
References

We have researched the literature with the utmost care. Nevertheless, we assume no liability for the completeness and up-to-dateness of the study information. Many of the therapy options mentioned in the product information are based on findings obtained from animal or human cell cultures, animal experiments, observational studies, and to a lesser extent, randomized controlled trials (RCTs).
The study situation for complementary medicines is subject to continuous development, which can sometimes lead to different results. We therefore recommend that therapists always carefully review the current study situation before using such preparations.

1) Gröber, U. 2008. Orthomolecular Medicine. A Guide for Pharmacists and Doctors

2) Gröber U. Micronutrients – Metabolic Tuning-Prevention-Therapy. Wissenschaftliche Verlagsgesellschaft, Stuttgart 2010

3) Böhm U, Muss C, Pfisterer M. Rational Diagnostics in Orthomolecular Medicine – Optimal Therapy through Individual Diagnostics. Hippokrates, 2004

4) Burgerstein, L. 2023. Handbook of Nutrients

5) Stossier H, Stossier G. Practical Handbook of Orthomolecular Medicine. Verlagshaus der Ärzte, 2023

6) Schmidt N, Schimdt E. Micronutrient Therapy. Urban & Fischer Verlag, 2022

7) Schmidbauer C, Hofstätter G. Micronutrient Coach – The Great BIOGENA Compendium of Nutrients. Verlagshaus der Ärzte, 2018

8) Venthan J Mailoo, Sanketh Rampes, Lysine for Herpes Simplex Prophylaxis: A Review of the Evidence, Integr med (Encinitas), 2017, 16(3):42-46

9) R Civitelli, D T Villareal, D Agnusdei, P Nardi, L V Avioli, C Gennari, Dietary L-lysine and calcium metabolism in humans, Nutrition, 1992, 8(6):400-5

10) Miro Smriga, Kunio Torii, L-Lysine acts like a partial serotonin receptor 4 antagonist and inhibits serotonin-mediated intestinal pathologies and anxiety in rats, Proc Natl Acad Sci U S A, 2003, 100(26):15370-5

11) E Malle, A Ibovnik, H J Leis, G M Kostner, P F Verhallen, W Sattler, Lysine modification of LDL or lipoprotein(a) by 4-hydroxynonenal or malondialdehyde decreases platelet serotonin secretion without affecting platelet aggregability and eicosanoid formation, Arterioscler Thromb Vasc Biol., 1995, 15(3):377-84

12) Miro Smriga, Toshihiko Ando, Masahisa Akutsu, Yasushi Furukawa, Kiyoshi Miwa, Yasushi Morinaga, Oral treatment with L-lysine and L-arginine reduces anxiety and basal cortisol levels in healthy humans, Biomed Res., 2007, 28(2):85-90